Ovarian cancer
Results
Phase 3
This trial looked at trabectedin and liposomal doxorubicin for recurrent ovarian cancer.
It was for women who had:
ovarian cancer
fallopian tube cancer
primary peritoneal cancer
Doctors treat these cancers in the same way. So when we use the term ovarian cancer in this summary, we are referring to all three.
Cancer Research UK supports this trial.
This trial was open for people to join between 2016 and 2017. The team published the results in 2020.
Recruitment start: 11 April 2016
Recruitment end: 18 September 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Ana Montes
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
Mario Negri Gynecologic Oncology Group (MaNGO)
National Cancer Research Institute (NCRI)
Pharma Mar
This is Cancer Research UK trial number CRUK/15/009
Last reviewed: 15 July 2021
CRUK internal database number: 14292
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
